Humacyte, Inc. — Investor Relations & Filings
Humacyte, Inc. is a regenerative medicine company that develops and manufactures universally implantable, bioengineered human tissues. The company utilizes a proprietary platform to produce acellular tissues that are designed to be available "off-the-shelf." Upon implantation, these tissues are repopulated by the patient's own cells, remodeling over time to become living tissue. Its first U.S. FDA-approved product, SYMVESS™, is a human acellular vessel (HAV) developed for arterial replacement and repair, particularly in cases of vascular trauma. Humacyte is leveraging its foundational technology to build a pipeline of product candidates for a broad range of diseases, injuries, and chronic conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM S-8 | 2026-05-14 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13D/A - Humacyte, Inc. (0001818382) (Subject) | 2026-03-24 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | |
| Major Shareholding Notification 2026 | 2026-01-09 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46302034 | FORM S-8 | 2026-05-14 | English | ||
| 36127809 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-04-24 | English | ||
| 33023654 | SCHEDULE 13D/A - Humacyte, Inc. (0001818382) (Subject) | 2026-03-24 | English | ||
| 32989361 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | ||
| 32986332 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | ||
| 13272830 | Major Shareholding Notification 2026 | 2026-01-09 | English | ||
|
2025
9 filings
| |||||
| 13272831 | FORM 8-K | 2025-12-16 | English | ||
| 13272832 | 424B5 | 2025-12-16 | English | ||
| 13272849 | FORM 8-K | 2025-12-15 | English | ||
| 13272848 | FORM 8-K | 2025-12-15 | English | ||
| 13272850 | 424B3 | 2025-12-15 | English | ||
| 13272833 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 13272837 | FORM 8-K | 2025-11-26 | English | ||
| 13272834 | FORM 4 | 2025-11-17 | English | ||
| 13272835 | FORM 4 | 2025-11-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | CA | Manufacturing |
|
Aurisco Pharmaceutical Co.,Ltd.
Develops and manufactures complex APIs and intermediates wi…
|
605116 | CN | Manufacturing |
|
Aurobindo Pharma Ltd.
Vertically integrated developer and manufacturer of generic…
|
AUROPHARMA | IN | Manufacturing |
|
Auro Laboratories Ltd.
Manufactures WHO-GMP compliant APIs and intermediates, spec…
|
530233 | IN | Manufacturing |
|
Aurora Cannabis Inc.
Global producer and distributor of cannabis products for me…
|
ACB | CA | Manufacturing |
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | CA | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | GB | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
Humacyte, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33410/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33410 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33410 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33410 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33410}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Humacyte, Inc. (id: 33410)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.